On September 15, 2025, Syensqo launched a new medical-grade Amodel®polyphthalamide (PPA). The glass-filled polymer is engineered for advanced single-use medical devices, delivering exceptional heat resistance, robust electrical properties, and key biocompatibility requirements for limited contact duration medical applications.
Amodel® PPA features a high melting point above 300 °C and maintains mechanical strength at temperatures up to 280 °C. These properties make it ideal for demanding manufacturing processes such as surface-mount technology (SMT) assembly, infrared (IR) reflow, and metal overmolding. The material is particularly well-suited for electrosurgical instruments and electronic device assemblies, where complex, injection-molded geometries offer advantages over alternative materials.
“For decades, brands like Radel® and Udel® have helped advance medical technologies. With medical-grade Amodel® PPA, we’re extending that legacy, giving customers a new option for devices that must withstand modern assembly processes,” said Natalie Dragunat, Global Marketing Manager, Healthcare at Syensqo.
Amodel® PPA medical-grade is available for sampling, with commercial availability expected in 2026.